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ABSTRACT
Background: Tumor of the follicular
infundibulum (TFI) is considered as a rare
benign neoplasm providing two distinctive
clinical patterns: the solitary and the eruptive
form. The clinical presentations resemble many
other dermatologic conditions and require
histopathological study to make a definite
diagnosis.
Objective: To inform physicians of a clinical
presentation of TFI.
Case Report: We report on a 50-year-old man
who presented with multiple asymptomatic
hypopigmented macules resistant to the
treatments. The histopathological study was
consistent with tumors of the follicular
infundibulum.
Conclusion: Hypopigmented macules are one
of the more common clinical presentations in
dermatological practices. It is important to
include TFI in the differential diagnosis when
a patient with hypopigmented lesions does not
respond to the treatment based on the clinical
diagnosis.
Keywords: Eruptive; Hypopigmentation;
Neoplasms; Tumor of the follicular
infundibulum
INTRODUCTION
Tumor of the follicular infundibulum (TFI) is a
rare benign neoplasm providing two distinctive
clinical patterns: the solitary and the eruptive
form. The clinical presentations resemble many
other dermatologic conditions and require
histopathological study to make a definite
diagnosis. TFI has a unique histopathological
finding but still debatable histogenesis.
Although the tumor is called a TFI, it is not a
neoplasm with infundibular differentiation.
The tumor differentiates towards the isthmus
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part of the follicular epithelium. We herein
report the case of a TFI patient who presented
with multiple asymptomatic hypopigmented
macules resistant to the treatments.
CASE REPORT
A 50-year-old man presented with a clinical
history of multiple asymptomatic lesions of the
face, neck, upper chest and back spanning more
than 20 years. The individual lesions were
hypopigmented angular-shaped scaly macules
with minimal central atrophy. The lesions were
symmetrically distributed in the affected area.
The size of the lesions ranged from
approximately 3 to 20 mm in diameter
(Fig. 1a, b). The patient was treated several
times for tinea versicolor and pityriasis alba
without success. Administration of 5% liquor
carbonis detergens for many years resulted in
only minimal improvement.
A biopsy was performed and
histopathologic examination revealed a plate-
like fenestrated subepidermal tumor extending
horizontally under the epidermis with
multiple cord-like connections to the
overlying epidermis. Peripheral palisading of
the basaloid cells was observed (Fig. 2a, b).
These histologic findings were consistent with
a TFI. This patient was treated with carbon
dioxide laser ablation.
Compliance with Ethics
All procedures followed were in accordance with
the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1975, as revised in 2000
and 2008. Informed consent was obtained from
all patients for being included in the study.
DISCUSSION
Tumor of the follicular infundibulum is
considered as a rare benign neoplasm, first
described by Mehregan and Butler in 1961 [1].
The incidence of TFI is still unknown. However,
the estimated frequency is 3–10 per 100,000
biopsies and the tumor develops predominantly
in women [2].
The clinical manifestations of TFI are
generally classified as the solitary and eruptive
form. The solitary form clinically shows no
distinctive features. Usually, solitary tumor
presents as scaly papule or nodule up to
Fig. 1 Hypopigmented angulated macules on face, neck (a) and upper chest (b)
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1.5 cm in diameter and distributed on the head
and neck or trunk of middle-aged and elderly
patients [2–4]. This form is frequently
misdiagnosed as seborrheic keratosis or basal
cell carcinoma. The eruptive form is rare and
appears much less frequently than the solitary
form. There are two research articles which
report its frequency. Abbas and Mahalingam
reported 3 cases of multiple TFI (6%) from 50
cases in 2009 and Alomari et al. reported 13
cases (7.7%) from total 168 cases in their study
[3, 4]. The eruptive form has been described in
most reports as symmetrically distributed
tumors of variable scaling, hypopigmented
macules and papules with irregular or
angulated borders confined to the face, neck
and upper trunk [3]. Rarely, the tumors occur
on the extremities and buttocks [5, 6]. The
number of tumors varies from fewer than
twenty to more than a hundred, and they are
usually asymptomatic [5]. There are some
reports of pruritus following sun exposure
[5, 6].
The differential diagnosis of TFI is one of the
most challenging issues because the tumor also
resembles many other dermatologic conditions.
Differential diagnosis of hypopigmented
macular lesions includes tinea versicolor,
pityriasis alba, vitiligo, tuberculoid leprosy and
idiopathic guttate hypomelanosis [3, 5]. For the
depressed lesions, differential diagnosis
includes acne scars, atrophic lichen planus,
lichen sclerosus et atrophicus, disseminated
superficial actinic porokeratosis and discoid
lupus erythematosus [3, 6]. Finally, differential
diagnosis of papular lesions includes basal cell
carcinoma, melanocytic nevi, seborrheic
keratosis, actinic keratosis, prurigo nodularis,
warts and trichoblastoma [3, 6, 7]. Because of
the variety of clinical presentations, the
histopathological study is the most important
method for providing a definite diagnosis.
Histopathological findings in both forms of
TFI consist of the plate-like growth of epithelial
cells in the upper part of the dermis, expanding
parallel to the epidermis, and showing
peripheral nuclear palisading of the individual
nest [2, 5, 8]. Some articles report an increase in
elastic fibers surrounding the tumor [2, 4]. The
histopathological difference between the
solitary and eruptive form is the decrease of
epidermal melanin, particularly in the tumor
area, which can be correlated with the clinical
form of hypopigmentation presented in the
Fig. 2 a Plate-like fenestrated subepidermal tumor extending horizontally under the epidermis with multiple cord-like
connections to the overlying epidermis (H&E 920). b Peripheral palisading of the basaloid cells (H&E 940)
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eruptive variant [2, 3]. Histologically, TFI
should be differentiated from basal cell
carcinoma, superficial fibroepithelial tumor of
Pinkus, trichilemmoma, inverted follicular
keratosis and pilar sheath acanthoma [4, 5].
The histogenesis of TFI has been
hypothesized. Most articles propose that the
origin of the tumor is the follicular
infundibulum, regarding the topography of
the tumor proliferation and glycogen in the
tumor cells [1, 2]. Others hypothesize that the
origin of the tumor is the isthmus part of the
follicle, regarding tumor cells showing
trichilemmal differentiation and the reports of
sebaceous differentiation [9, 10].
TFI is generally considered to be a chronic
benign adnexal tumor. The eruptive form has
been reported in association with Cowden’s
disease, nevus sebaceous, actinic keratosis,
junctional melanocytic nevus, desmoplastic
malignant melanoma, trichilemmoma,
epidermal inclusion cysts and transformation
to basal cell carcinoma [2]. However, the
associations are not strong and should be
considered only in additional cases which raise
clinical concerns.
Treatments reported for TFI include topical
steroids, topical retinoic acid, topical
keratolytics, topical imiquimod, etretinate,
cryotherapy, curettage, excision and ablative
laser, all with unpleasant results [6]. There was a
reported case of 10 months recurrence
following excision [4]. Our patient was treated
with carbon dioxide laser ablation and the
short-term result was satisfactory. Although
only a single reported case of transformation
to basal cell carcinoma exists, the possibility of
this outcome should be considered [11, 12].
Long-term follow-up, especially in the case of
eruptive form, should be performed since
complete treatment is not practicable.
CONCLUSION
In conclusion, we report the case of TFI to
remind physicians of the clinical presentation
of this rare tumor. Moreover, hypopigmented
macules are one of the more common clinical
presentations in dermatological practices. TFI
should be included in the differential diagnosis
when a patient with hypopigmented lesions,
particularly on the head and neck area, does not
respond to the treatment based on the clinical
diagnosis.
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